- Advertisement -
Thursday, May 13, 2021
- Advertisement -

BioNTect: Able to make COVID-19 vaccine against the new strain within 6 weeks

BioNTech could make a new COVID-19 vaccine within six week against the new variant if their existing vaccine proves ineffective against the strain.

00:02:43

The Ageless Musical Maestro – Bob Marley | Rare Video

Here's the rare and unseen video of The Ageless Musical Maestro - Bob Marley. Bob Marley, OM (6 February 1945 – 11 May 1981)...
00:03:04

The King of Latin Pop – Enrique Iglesias | UNSEEN VIDEO

Today, as the Spanish superstar Enrique Iglesias is turning 46, We have brought an unseen and rare video of the singer which I'm sure...
00:02:28

Usher – Evolution As An Entertainer | Unseen Footage

Have a look at unseen footage of Usher - Evolution As An Entertainer. One of the most successful pop-R&B artists of the late 20th century...

BioNTech could make a vaccine within 6 weeks against the new strain recently discovered in the United Kingdom. The German-based pharma company is confident that its COVID-19 vaccine will work against the new variant. According to Ugur Sahin, the co-founder of BioNTech, the vaccine is highly likely to work against the new strain. The immune response triggered by the vaccine can counter the virus strain. However, not much data is present to prove the effectiveness of the vaccine against the variant.

Sahin also said that the proteins present on the new strain are 99% similar to the existing strains. Hence, the pharma company is confident about its scientific assumptions about its vaccine. However, researchers need about two-week time to provide ample data supporting these assumptions.

Also Read – Vaccine Update: India likely to approve Oxford COVID-19 Vaccine

The co-founder also said that the company shall roll-out a new vaccine within six weeks if the need be. If their vaccine isn’t effective against the new strain, they are willing to develop a dose to combat the mutated variant. Using ‘messenger technology’, the firm can directly create a vaccine that mimics the new variant. In this way, BioNTech might just be able to roll-out a vaccine within a short period.

BioNTech previously joined hands with Pfizer Inc. to develop a vaccine against the novel coronavirus. Their vaccine became one of the first to get approval for use in more than 45 countries including the United States, European Union and Britain.

Moderna is also conducting tests to check whether the vaccine works against the mutated strain, according to a CNN report. Moderna recently spoke that based on the available data, it expects the vaccine-induced immunity to fight against the new variant. Additional tests will be performed to confirm this assumption.

Must Read – New COVID Strain: Know which countries have confirmed the virus variant

UK recently reported a new COVID-19 variant which is 70% more infectious than the existing strains. Several countries including Italy, South Africa and Australia have reported the cases caused by the strain. Many nations including India have temporarily banned flights to the UK to counter the COVID-19 pandemic.   

Movie Review: Radhe – Your Most Wanted Bhai

Prabhu Devaa and Salman Khan’s Wanted had a timely twist and comic action. The antique Radhe has neither.  What it has is Salman Khan wishing his...

Ankit Siwach: The Term Star Has Become Metaphorical

In his recent interview, currently seen playing the stylised antagonist multilayered character of Vyom in dynamic producer duo Yash and Mamta Patnaik’s hit serial Ishq Mein Marjawan...

Anjali Phogat Reveals Her Experience of Interviewing Sonu Nigam

In her recent interview, US based Indian origin fashion designer Anjali Phogat reveals her experience of interviewing Sonu Nigam. Opening up on more on the...
- Advertisement -